Confederation of Indian Industry and U.S.-India Business Council Announce Healthcare Partnership
Business Wire, Nov 06, 2009
NEW DELHI, India — The Confederation of Indian Industry and the U.S.-India Business Council
today announced a major new advance in healthcare collaboration,
partnering under the banner of the USIBC-led Coalition for Healthy
India. The partnership was announced on the sidelines of CIIs 6th
Annual Healthcare Summit, which was attended by a delegation of senior
healthcare executives from the headquarters of several USIBC member
companies.
The Coalition for Healthy India, managed by the US India Business
Council, is dedicated to ensuring that Indian patients have access to
the latest and most effective treatments and cures. It was created in
2007 to bring together like-minded members of the U.S. and Indian
business communities, non-governmental organizations, patient advocacy
organizations and health professionals to coordinate and support
improved access to healthcare in India.
According to Mr. Chandrajit Banerjee, Director General, Confederation of
Indian Industry: The Confederation of Indian Industry and the
U.S.-India Business Council have long collaborated to support healthcare
improvements in India. Today, were proud to announce an exclusive
partnership between USIBC and CII in the form of a joint CII-USIBC
Healthcare Task Force.
Sharing the dais was Dr. Petra Laux, Head of Global Public Affairs,
Novartis. At Novartis, were driven every day by a commitment to
research and development that brings innovative new products to the
communities we serve. This aligns seamlessly with the number one goal of
the Coalition for Healthy India ensuring that Indian patients have
access to the latest and best treatments and cures. The partnership
announced with CII today will lift the Coalition for Healthy India to
new heights.
Dr. Prathap C Reddy, Chairman CII National Committee on Healthcare &
Chairman of Apollo Hospitals Group, noted that the healthcare systems of
the U.S. and India have much to learn from one another. The partnership
were announcing under the Coalition for Healthy India brings together
the foremost healthcare innovators from two of the worlds most dynamic
societies. This will not only have a positive impact on patients in
India, it will benefit patients around the globe.
The Coalition for Healthy India focuses on five key pillars: raising the
standard of care; developing new treatments and cures; ensuring access
and affordability; getting medicine to patients; and corporate social
responsibility. All of these efforts are channeled with a particular
emphasis on improving the situation in rural areas where more than 60%
of Indians live and work.
The Coalition for Healthy India Healthcare Task Force will serve as an
advisory council which guides and coordinates USIBC and CII efforts
towards improving healthcare in India. The Task Force will be chaired on
the Indian side by Dr. Prathap C. Reddy and on the U.S. side by Dr. Vas
Narasimhan, Head, sacramento homes Vaccines North America, President, Vaccines USA,
Novartis Vaccines & Diagnostics, and board member of the U.S.-India
Business Council.
Dr. John D. Ayres, Director, Product Health Risk Assessments, Eli Lilly
and Company, stated: The Coalition for Healthy India is poised to have
a major impact on issues that are important to patients. This
collaboration between USIBC and CII means that healthcare innovators in
the U.S. and India will now have a permanent forum in which to share and
generate new ideas and ultimately help implement solutions to the
healthcare challenges facing all of us.
Coalition for Healthy India brings together like-minded members
of the U.S